Cargando…

Precision Oncology: Evolving Clinical Trials across Tumor Types

SIMPLE SUMMARY: Precision oncology is the use of anticancer drugs to specifically inhibit the function of aberrant oncogenic proteins driving a patient’s tumor. The application of molecular technologies and targeted therapeutics has led to significant advancements in precision oncology, resulting in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, I-Wen, Vo, Henry Hiep, Chen, Ying-Shiuan, Baysal, Mehmet A., Kahle, Michael, Johnson, Amber, Tsimberidou, Apostolia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093499/ https://www.ncbi.nlm.nih.gov/pubmed/37046628 http://dx.doi.org/10.3390/cancers15071967

Ejemplares similares

Clinical trial design in the era of precision medicine
por: Fountzilas, Elena, et al.
Publicado: (2022)

Circulating tumor DNA analysis in the era of precision oncology
por: Said, Rabih, et al.
Publicado: (2020)

Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology
por: Vo, Henry Hiep, et al.
Publicado: (2022)

Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series
por: Naqvi, Mohammad Faraz, et al.
Publicado: (2021)

Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancers
por: Fountzilas, Elena, et al.
Publicado: (2023)

First-in-Human Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors
por: Tsimberidou, Apostolia Maria, et al.
Publicado: (2023)

T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
por: Tsimberidou, Apostolia-Maria, et al.
Publicado: (2021)

Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
por: Bulliard, Yannick, et al.
Publicado: (2023)

Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center
por: Vo, Henry Hiep, et al.
Publicado: (2022)

AKT inhibition in the central nervous system induces signaling defects resulting in psychiatric symptomatology
por: Tsimberidou, Apostolia-Maria, et al.
Publicado: (2022)

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials
por: Le Tourneau, Christophe, et al.
Publicado: (2015)

Precision oncology for RET-related tumors
por: Verrienti, Antonella, et al.
Publicado: (2022)

Precision Oncology in Gastrointestinal Stromal Tumors
por: Mechahougui, Hiba, et al.
Publicado: (2023)

Dasatinib in chronic myeloid leukemia: a review
por: Aguilera, Dolly G, et al.
Publicado: (2009)

Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement
por: Tsimberidou, Apostolia M., et al.
Publicado: (2018)

Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits
por: Fountzilas, Elena, et al.
Publicado: (2018)

Trailblazing Precision Oncology for Rare Tumor Subtypes
por: Shee, Kevin, et al.
Publicado: (2017)

Circulating tumor cell profiling for precision oncology
por: Labib, Mahmoud, et al.
Publicado: (2021)

Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine
por: Hugen, Cory M., et al.
Publicado: (2017)

The evolving landscape of thoracic surgical oncology
por: Kim, Anthony W., et al.
Publicado: (2023)

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network
por: Dias-Santagata, Dora, et al.
Publicado: (2022)

Precision Oncology Comes of Age: Tumor-Agnostic Approaches
por: Lewis, Colleen, et al.
Publicado: (2020)

Clinical Circulating Tumor DNA Testing for Precision Oncology
por: Kim, Hyunji, et al.
Publicado: (2023)

Targeted treatment of solid tumors in pediatric precision oncology
por: Bertacca, Ilaria, et al.
Publicado: (2023)

Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative
por: Fountzilas, Elena, et al.
Publicado: (2020)

Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology
por: Kang, Sandra Mirie, et al.
Publicado: (2022)

Dietary Oncopharmacognosy as a Crosswalk between Precision Oncology and Precision Nutrition
por: Thompson, Henry J., et al.
Publicado: (2023)

Transplant Oncology: An Evolving Field in Cancer Care
por: Abdelrahim, Maen, et al.
Publicado: (2021)

Actionability and precision oncology
por: Schwaederle, Maria, et al.
Publicado: (2015)

Bioinformatics for precision oncology
por: Singer, Jochen, et al.
Publicado: (2017)

The Future of Precision Oncology
por: Rulten, Stuart L., et al.
Publicado: (2023)

The evolving EU regulatory framework for precision breeding
por: Eriksson, Dennis
Publicado: (2018)

Precision medicine in neurosurgery: The evolving role of theranostics
por: Patel, Drashti, et al.
Publicado: (2023)

A single-cell tumor immune atlas for precision oncology
por: Nieto, Paula, et al.
Publicado: (2021)

An Emerging Role for Radiation Oncology in Precision Oncology
por: Goyal, Sharad, et al.
Publicado: (2016)

Phase 1 dose-escalation study evaluating the safety, pharmacokinetics, and clinical activity of OBI-3424 in patients with advanced or metastatic solid tumors
por: Tsimberidou, Apostolia Maria, et al.
Publicado: (2023)

Evolving Concepts: Immunity in Oncology from Targets to Treatments
por: Khan, Hina, et al.
Publicado: (2015)

Payment Reform: Unprecedented and Evolving Impact on Gynecologic Oncology
por: Apte, Sachin M., et al.
Publicado: (2016)

Evolving role of biomaterials in diagnostic and therapeutic radiation oncology
por: Shi, Siyu, et al.
Publicado: (2020)

Mechanisms of resistance to PARP inhibitors - an evolving challenge in oncology
por: Mweempwa, Angela, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2hb191dsvlvan9nig13mde5j1r